Pacific Biosciences of California, Inc. Stock
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 USD | -7.48% | -2.86% | -86.14% |
Financials (USD)
Sales 2024 * | 193M | Sales 2025 * | 285M | Capitalization | 400M |
---|---|---|---|---|---|
Net income 2024 * | -283M | Net income 2025 * | -235M | EV / Sales 2024 * | 4.31 x |
Net Debt 2024 * | 432M | Net Debt 2025 * | 502M | EV / Sales 2025 * | 3.17 x |
P/E ratio 2024 * |
-1.31
x | P/E ratio 2025 * |
-1.61
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.18% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | -7.48% | ||
1 week | -2.86% | ||
Current month | -63.73% | ||
1 month | -63.04% | ||
3 months | -80.65% | ||
6 months | -81.27% | ||
Current year | -86.14% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.87% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1.36 | -7.48% | 10,982,631 |
24-04-23 | 1.47 | -5.77% | 9,818,090 |
24-04-22 | 1.56 | +0.65% | 8,964,453 |
24-04-19 | 1.55 | +6.16% | 16,879,745 |
24-04-18 | 1.46 | +4.29% | 18,742,356 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.14% | 400M | |
+8.78% | 219B | |
+8.24% | 187B | |
+11.16% | 134B | |
+26.12% | 101B | |
+0.30% | 62.27B | |
+16.21% | 52.82B | |
-1.63% | 47.49B | |
-1.11% | 40.79B | |
+12.16% | 39.35B |
- Stock Market
- Equities
- PACB Stock